555400218	555400218	CD	B-NP	O
|	|	NN	I-NP	O
CUC	CUC	NN	I-NP	O
|	|	NN	I-NP	O
91355779	91355779	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
839132	839132	CD	B-NP	O
|	|	CC	I-NP	O
7/9/1994	7/9/1994	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/4/1994	10/4/1994	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/5/1994	3/5/1994	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
SECONDARY	SECONDARY	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

PULMONARY	PULMONARY	NN	B-NP	B-protein
EMBOLUS	EMBOLUS	NNS	I-NP	I-protein
2	2	CD	B-NP	I-protein
.	.	.	O	O

DILATED	DILATED	VBN	B-NP	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
pleural	pleural	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
returns	return	VBZ	B-VP	O
now	now	RB	B-ADVP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
phlegm	phlegm	NN	I-NP	O
and	and	CC	O	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
in	in	IN	B-PP	O
1989	1989	CD	B-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	B-protein
lumpectomy	lumpectomy	NN	I-NP	I-protein
x	x	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
and	and	CC	I-NP	O
XRT	XRT	NN	I-NP	B-DNA
,	,	,	O	O
accompanied	accompany	VBN	B-VP	O
by	by	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
completed	complete	VBN	B-VP	O
in	in	IN	B-PP	O
early	early	JJ	B-NP	O
1990	1990	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
July	July	NNP	B-NP	O
of	of	IN	B-PP	O
1992	1992	CD	B-NP	O
with	with	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
felt	feel	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Digoxin	Digoxin	NNP	B-NP	O
,	,	,	I-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	I-NP	O
Captopril	Captopril	NNP	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NNP	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
subsequent	subsequent	JJ	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
SVT	SVT	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
180	180	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
eventually	eventually	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
EPEP	EPEP	NN	B-NP	O
studies	study	NNS	I-NP	O
with	with	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
ablation	ablation	NN	I-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
done	do	VBN	I-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
until	until	IN	B-SBAR	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1994	1994	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
phlegm	phlegm	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
and	and	CC	I-NP	O
left-sided	left-sided	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
empiric	empiric	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
with	with	IN	B-PP	O
little	little	JJ	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
8/7	8/7	CD	B-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
left-sided	left-sided	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
ultrasound	ultrasound	JJ	B-NP	O
guided	guide	VBN	I-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
requiring	require	VBG	B-VP	O
chest	chest	NN	B-NP	O
tube	tube	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Evaluation	Evaluation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
transudative	transudative	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	I-NP	O
cytology	cytology	NN	I-NP	O
remaining	remain	VBG	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Ancef	Ancef	NN	B-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
6/20/94	6/20/94	CD	B-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
but	but	CC	O	O
rather	rather	RB	B-NP	O
notes	note	NNS	I-NP	O
increasing	increase	VBG	B-VP	O
cough	cough	NN	B-NP	O
which	which	WDT	B-NP	O
remains	remain	VBZ	B-VP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
``	``	``	I-NP	O
specks	speck	NNS	I-NP	O
of	of	IN	B-PP	O
red	red	JJ	B-NP	O
''	''	''	O	O
and	and	CC	O	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
six	six	CD	B-NP	O
steps	step	NNS	I-NP	O
of	of	IN	B-PP	O
stair	stair	NN	B-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
approximately	approximately	RB	B-NP	O
one	one	CD	I-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
two	two	CD	B-NP	O
flights	flight	NNS	I-NP	O
without	without	IN	B-PP	O
extreme	extreme	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
3	3	CD	I-NP	O
+	+	SYM	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	O	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
has	have	VBZ	B-VP	O
increased	increase	VBN	I-VP	O
only	only	RB	B-ADVP	O
slightly	slightly	RB	I-ADVP	O
recently	recently	RB	I-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
sweats	sweat	NNS	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
or	or	CC	O	O
pleuritic	pleuritic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	O	O
anorexia	anorexia	NN	B-NP	O
and	and	CC	I-NP	O
malaise	malaise	NN	I-NP	O
without	without	IN	B-PP	O
myalgias	myalgia	NNS	B-NP	O
or	or	CC	I-NP	O
arthralgias	arthralgia	NNS	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Dilated	Dilate	VBN	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	I-PP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Breast	Breast	NN	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
as	as	IN	B-PP	O
above	above	RB	I-PP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypothyroid	Hypothyroid	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Depression	Depression	NN	B-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

Habits	Habit	NNS	B-NP	O
,	,	,	O	O
distant	distant	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
none	none	NN	B-NP	O
since	since	IN	B-PP	O
1967	1967	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ETOH	ETOH	NN	I-NP	B-protein
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Capoten	Capoten	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
one	one	CD	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
2	2	CD	I-NP	O
gr	gr	NN	I-NP	O
.	.	.	O	O

per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Tamoxifen	Tamoxifen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Elavil	Elavil	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
K-Dur	K-Dur	NN	B-NP	O
1	1	CD	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
boyfriend	boyfriend	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
widowed	widow	VBN	I-VP	O
without	without	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
semi-retired	semi-retired	JJ	I-NP	O
Accounts	Accounts	NNP	I-NP	O
Manager	Manager	NNP	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
100.6	100.6	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
116/65	116/65	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
is	be	VBZ	B-VP	O
100	100	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

02	02	CD	B-NP	O
saturation	saturation	NN	I-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
,	,	,	I-NP	O
responsive	responsive	JJ	I-NP	O
,	,	,	I-NP	O
febrile	febrile	JJ	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
conjunctiva	conjunctiva	NN	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-NP	O
,	,	,	I-NP	O
extraocular	extraocular	JJ	I-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
8	8	CD	I-NP	O
cm	cm	NN	I-NP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
degrees	degree	NNS	I-NP	O
.	.	.	O	O

Lung	Lung	NN	B-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
rales	rale	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
base	base	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
with	with	IN	B-PP	O
dullness	dullness	NN	B-NP	O
to	to	TO	B-PP	O
percussion	percussion	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
SI	SI	NN	I-NP	O
,	,	,	O	O
SII	SII	NN	B-NP	B-protein
,	,	,	O	O
positive	positive	JJ	B-NP	O
SIII	SIII	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
non-tender	non-tender	JJ	I-ADJP	O
,	,	,	O	O
slightly	slightly	RB	B-ADJP	O
distended	distended	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
pitting	pit	VBG	I-VP	O
edema	edema	NN	B-NP	O
almost	almost	RB	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
examination	examination	NN	I-NP	O
is	be	VBZ	B-VP	O
non	non	JJ	B-NP	O
focal	focal	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
SMA-7	SMA-7	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
5.4	5.4	CD	B-NP	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
BUN	BUN	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

CBC	CBC	NN	B-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
42.9	42.9	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
289	289	CD	B-NP	I-protein
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
right	right	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
+	+	SYM	B-VP	O
-	-	HYPH	O	O
consolidation	consolidation	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
98	98	CD	B-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
7/24/94	7/24/94	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
picture	picture	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
progressive	progressive	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
grade	grade	NN	I-NP	O
fevers	fever	NNS	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
new	new	JJ	B-NP	O
opacity	opacity	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
picture	picture	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mostly	mostly	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
progressive	progressive	JJ	I-NP	O
infectious	infectious	JJ	I-NP	O
process	process	NN	I-NP	O
superimposed	superimpose	VBN	B-VP	O
on	on	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
versus	versus	IN	B-PP	O
post-obstructive	post-obstructive	JJ	B-NP	O
infection	infection	NN	I-NP	O
versus	versus	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
endobronchial	endobronchial	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
including	include	VBG	B-PP	O
cefotaxime	cefotaxime	NN	B-NP	O
and	and	CC	I-NP	O
clarithromycin	clarithromycin	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
consultation	consultation	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Service	Service	NNP	I-NP	O
which	which	WDT	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
was	be	VBD	B-VP	O
warranted	warrant	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
more	more	RBR	I-NP	O
aggressive	aggressive	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
bronchoscopy	bronchoscopy	NN	B-NP	O
or	or	CC	I-NP	O
repeat	repeat	NN	I-NP	O
thoracentesis	thoracentesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
IV	IV	CD	I-NP	O
diuresis	diuresis	NN	I-NP	O
with	with	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
symptomatic	symptomatic	JJ	I-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
cleared	clear	VBD	B-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
valuable	valuable	JJ	B-ADJP	O
in	in	IN	B-PP	O
evaluating	evaluate	VBG	B-VP	O
her	her	PRP	B-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
endobronchial	endobronchial	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
volume	volume	NN	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
thus	thus	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
2/6/94	2/6/94	CD	B-NP	O
with	with	IN	B-PP	O
demonstration	demonstration	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
peripheral	peripheral	JJ	I-NP	O
,	,	,	I-NP	O
red	red	JJ	I-NP	O
,	,	,	I-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
,	,	,	O	O
highly	highly	RB	B-ADJP	O
suggestive	suggestive	JJ	I-ADJP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
endobronchial	endobronchial	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
or	or	CC	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
off	off	RB	B-ADVP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
discussion	discussion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chest	ch	JJS	I-NP	O
CT	CT	NN	I-NP	O
findings	finding	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Chest	Chest	NNP	I-NP	O
Radiologist	Radiologist	NNP	I-NP	O
and	and	CC	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
Consult	Consult	NNP	I-NP	O
Team	Team	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
Heparin	Heparin	NN	I-NP	O
with	with	IN	B-PP	O
achievement	achievement	NN	B-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
PTT	PTT	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
switching	switch	VBG	B-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
non-invasives	non-invasive	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
RV	RV	NN	B-NP	O
strain	strain	NN	I-NP	O
or	or	CC	O	O
right	right	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
again	again	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
moderately	moderately	RB	B-NP	O
large	large	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
severely	severely	RB	B-NP	O
depressed	depressed	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Though	Though	IN	B-SBAR	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
wedge	wedge	NN	I-NP	O
shaped	shape	VBD	B-VP	O
opacification	opacification	NN	B-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	O
was	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
infarction	infarction	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
low	low	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
she	she	PRP	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
basis	basis	NN	I-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
thus	thus	RB	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
angiogram	angiogram	NN	I-NP	O
or	or	CC	I-NP	O
VQ	VQ	NN	I-NP	O
scan	scan	NN	I-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
alter	alter	VB	I-VP	O
management	management	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Elavil	Elavil	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
;	;	:	O	O
Captopril	Captopril	NNP	B-NP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
Biaxin	Biaxin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
0.25	0.25	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Tamoxifen	Tamoxifen	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Thyroid	Thyroid	NN	B-NP	B-protein
2	2	CD	B-NP	I-protein
grains	grain	NNS	I-NP	I-protein
p.o.	p.o.	FW	B-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
Ambien	Ambien	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
Followup	Followup	NNP	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gunsolus	Gunsolus	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Leyer	Leyer	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
AHMED	AHMED	NNP	B-NP	O
M.	M.	NNP	I-NP	O
HEILIGER	HEILIGER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SK04	SK04	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ELWOOD	ELWOOD	NNP	B-NP	O
A.	A.	NNP	I-NP	O
COGGSDALE	COGGSDALE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SH3	SH3	NNP	I-NP	O
QG218/6051	QG218/6051	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
7155	7155	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

PTEY6LF96	PTEY6LF96	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/10/94	3/10/94	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/10/94	8/10/94	CD	B-NP	O

